What is Abraxane carboplatin?

Carboplatin + Abraxane® (Paclitaxel protein-bound particles); is a Chemotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)

How is gemcitabine and Abraxane administered?

This treatment is usually given in an outpatient infusion center, allowing the person to go home afterwards. These drugs are repeated every 28 days. This is known as one Cycle. Each cycle may be repeated up to six times (six months), depending upon response, tolerability, and number of cycles prescribed.

What is the difference between paclitaxel and Abraxane?

Abraxane is a new form of paclitaxel that is bound with albumin, a type of protein normally found in the human body. This form of paclitaxel delivers high concentrations of the active ingredient into the cancer cells and, compared to the original form of the drug, reduces the incidence of side effects.

What is carboplatin and gemcitabine?

Each of the medications in carboplatin + gemcitabine are chemotherapy drugs designed to both slow the growth of and kill lung cancer cells. Goals of therapy: Carboplatin + gemcitabine (or “carbo/gem”) is given to shrink exisiting lung cancer nodules, slow the spread of lung cancer and decrease symptoms.

What cancers does Abraxane treat?

This medication is used to treat certain cancers (including breast, lung, and pancreatic cancer). Paclitaxel belongs to a class of drugs known as chemotherapy drugs. It works by slowing or stopping the growth of cancer cells.

What is Abraxane approved for?

ROCKVILLE, Maryland—Abraxane (paclitaxel protein-bound particles for injectable suspension, American Bioscience) has received Food and Drug Administration approval for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.

How effective is gemcitabine and Abraxane?

Induction treatment with nab-paclitaxel (Abraxane) plus gemcitabine demonstrated a time to treatment failure (TTF) of 8.8 months (90% CI, 6.67-9.82) for patients with newly diagnosed locally advanced pancreatic cancer, according to updated findings from the phase II LAPACT trial presented at the 2018 Gastrointestinal …

What is gemcitabine and Abraxane?

Gemcitabine and nab-paclitaxel (Abraxane®) is a combination treatment used to treat advanced cancer of the pancreas. It is best to read this information with our general information about chemotherapy and the type of cancer you have.

Will I lose all my hair with Abraxane?

Your hair may become thin, brittle, or may fall out. This typically begins two to three weeks after treatment starts. This hair loss can be all body hair, including pubic, underarm, legs/arms, eyelashes, and nose hairs.

What kind of chemo is gemcitabine?

Drug Type: Gemcitabine is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Gemcitabine is classified as an antimetabolite.

What cancers does gemcitabine treat?

Gemcitabine, a pyrimidine nucleoside antimetabolite, is one of the most promising new cytotoxic agents. The drug has shown activity in a variety of solid tumors, and has been approved for the treatment of non-small cell lung cancer, pancreatic, bladder, and breast cancer.

What is the success rate of Abraxane?

RESULTS: The treatment completion rate of the 4 cycles was 90.9%. The objective response rate was 13.6% and the disease control rate was 63.6%. The median progression-free survival was 7.2 months. The most common grade 3 or higher hematological toxicity was neutropenia (72.7%).

What is gemcitabine Abraxane?

How many cycles of Abraxane is normal?

Adenocarcinoma of the Pancreas The recommended dose of ABRAXANE is 125 mg/m2 administered as an intravenous infusion over 30-40 minutes on Days 1, 8 and 15 of each 28-day cycle.

Do you lose your hair with Abraxane?

The most common side effects of ABRAXANE in people with breast cancer include: hair loss. numbness, tingling, pain, or weakness in the hands or feet.

What is Abraxane used for?

Nab-paclitaxel is a chemotherapy drug and is also known by its brand name, Abraxane. It combines the chemotherapy drug paclitaxel with a protein called albumin. It is a treatment for: breast cancer that has spread.

Does Abraxane cause weight gain?

This treatment may cause a build-up of fluid. You may gain weight, or your face, ankles and legs may swell.

What is survival rate of patients getting gemcitabine?

Background: Adjuvant chemotherapy following curative resection is the standard treatment for pancreatic adenocarcinoma (PC). Randomized clinical trials using gemcitabine have shown a median overall survival (mOS) of 2 years and a 5-year survival rate of 15-20%.

What are the side effects of carboplatin and abraxane together?

The most common ARs (≥20%) of ABRAXANE in combination with carboplatin are anemia, neutropenia, thrombocytopenia, alopecia, peripheral neuropathy, nausea, and fatigue. P =0.005 (based on chi-square test).

What is the AUC for gemcitabine 1000 mg/m2?

From February 2002 to May 2003, 30 previously treated patients with adenocarcinoma of the breast received gemcitabine 1000 mg/m2 on days 1 and 8 plus carboplatin to an area under the curve (AUC) of 5 on day 1. The carboplatin dose was changed to an AUC of 4.5 because of toxicity, with cycles repeated every 3 weeks.

Is gemcitabine plus carboplatin a safe second-line treatment for metastatic breast cancer?

This study was designed to determine the safety and efficacy of the combination therapy of gemcitabine plus carboplatin when used as a second-line treatment in patients with metastatic breast cancer (MBC).

When should I take gemcitabine after Abraxane?

Administer gemcitabine immediately after ABRAXANE on Days 1, 8 and 15 of each 28-day cycle [see Clinical Studies (14.3)]. aminotransferase [AST] less than or equal to 10 x ULN), no dose adjustments are required, regardless of indication.